LVGO Insider Trading Activity and SEC Form 4 Filings
LVGO insider trading summary
No open-market insider purchases or sales of Livongo Health, Inc. (LVGO) have been reported on SEC Form 4 in the past 12 months.
Latest LVGO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 14, 2020 | Lee Shapiro | Chief Financial Officer | Sell | $3K (23 @ $124.46) |
| Sep 14, 2020 | Glen Tullman | Executive Chairman | Sell | $3K (23 @ $124.46) |
| Sep 11, 2020 | Karen L Daniel | Director | Sell | $1.9M (15,000 @ $126.71) |
| Sep 8, 2020 | Philip D Green | Director | Sell | $62K (500 @ $123.38) |
| Sep 8, 2020 | Philip D Green | Director | Sell | $37K (300 @ $123.82) |
| Sep 8, 2020 | Philip D Green | Director | Sell | $1.2M (9,500 @ $122.90) |
| Sep 8, 2020 | Philip D Green | Director | Sell | $1.2M (10,000 @ $122.97) |
| Sep 8, 2020 | Philip D Green | Director | Sell | $1.2M (9,700 @ $122.98) |
| Sep 4, 2020 | James Pursley | Chief Commercial Officer | Sell | $120K (940 @ $128.00) |
| Sep 4, 2020 | James Pursley | Chief Commercial Officer | Sell | $1.3M (10,773 @ $124.41) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.